Authors
Loading...
Immunophenotyping shows immune dysfunction and altered NK and T cell profiles in myelofibrosis, indicating targets for immunomodulatory therapies.
Medeiros et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: